PRIMEBODYMIND · THE LONGEVITY JOURNAL · WEALTH · MIND

The longevity economy, documented.

PrimeBodyMind is the journal of the fastest-growing category in medicine — the doctors leading it, the science underneath it, and the wealth being created by the people who showed up early with standards. Best practices from the field, documented since 2024.

A PRIMEBODYRX.COM PUBLICATION · VOL. 1 · EST. 2024 · UPDATED SEPTEMBER 2026|WRITTEN BY BROOKES BRUNO · FOUNDER, PRIMEBODYRX|PRIMEBODYRX.COM
01 · THE CATEGORY, IN NUMBERS

Read the numbers before you read anything else

Editorial desk of the PrimeBodyMind longevity journal
$1T
Eli Lilly market value — the first drugmaker in history to cross a trillion, powered by GLP-1s
$200B
Projected GLP-1 market by 2030 — J.P. Morgan global research forecast
$78B
Projected medspa market by 2033, from $21B in 2024 — a 16% annual growth curve
$101M
XPRIZE Healthspan — the largest health prize in history, now in clinical trials with ten finalist teams

This is not a trend chart. It is a wealth-creation record — capital, clinics, and compounds moving in the same direction at the same time. The posts below document how it happened, and what the people winning are doing about it.

02 · THE JOURNAL — 2024 TO NOW

Best practices from the field, newest first

2026 · SEPTEMBER
6 MIN
MARKET

The category gets organized

The wild-west phase is ending. The consumer peptide channels are being banned and raided; the FTC and FDA are circling the gray market; and what replaces it is wholesale-only B2B infrastructure — 503A/503B sourcing networks, physician oversight, integrated financing, and one login for the entire practice economy. The best practice, written plainly: plug into infrastructure instead of building it. The winners of the next decade are the practices and professionals who chose systems over reinvention — and recurring revenue over one-off sales.

Presented by PrimeBodyRx.com
2026 · AUGUST
5 MIN
HEALTH

The XPRIZE decade begins

XPRIZE Healthspan — the largest health prize in history at $101 million — named its ten finalist teams, each awarded $1 million to test real therapies that restore muscle, cognitive, and immune function in people over 65. After two decades of theory, the science is now on a clock and moving toward the clinic. The best practice: position your practice now, because when functional healthspan therapies arrive, the patients and the capital will look for the practices that were already built for them.

Presented by PrimeBodyRx.com
2025 · WINTER
4 MIN
HEALTH

Muscle is the currency

Dr. Gabrielle Lyon’s muscle-centric medicine went mainstream with Forever Strong, and the clinical consensus moved with it: lean mass is the organ of longevity — the thing that protects against the falls, the frailty, and the glucose curves that end healthspans early. GLP-1-era medicine now pairs every weight-loss protocol with a strength protocol, and patients stay on plans they can feel. The best practice: protein-first, strength-first medicine — it is the protocol members actually keep paying for.

Presented by PrimeBodyRx.com
The Associate Channel

Living this — fitness, clean eating, real discipline — and want to represent it professionally instead of just posting about it? There’s a B2B channel built for people exactly like you. See the Associate Program →

2025 · FALL
4 MIN
WEALTH

The protocol economy gets funded

Bryan Johnson’s Blueprint raised $60 million to turn a personal longevity protocol into a product company — a watershed moment for the category. The message Wall Street sent: measured, documented protocols are sellable assets. Every practice running a documented protocol with outcomes data is holding the same asset at clinic scale. The best practice: write your protocols down, measure them, and treat them like products — because the market already does.

Presented by PrimeBodyRx.com
2025 · SPRING
5 MIN
WEALTH

The clinic is the new gym

The longevity clinic stopped being a concept and became a membership business. The medspa market — $21 billion in 2024, projected toward $78 billion by 2033 — began consolidating around recurring protocol plans: GLP-1 management, peptide programs, hormone panels, IV therapy. The success stories repeating across the country are single-location practices that stopped selling one-off visits and started selling systems of care with monthly revenue. Same chairs, same square footage, entirely different business.

Presented by PrimeBodyRx.com
2024 · YEAR-END
4 MIN
MIND

Outlive, and the informed patient

Dr. Peter Attia’s Outlive became the category’s defining book, and The Drive podcast became its faculty lounge. The result in clinics across the country: patients now arrive educated, asking for protocols by name — NAD+, peptides, GLP-1 maintenance, hormone optimization. The best practice: meet the informed patient with clinical documentation, not improvisation. The practices that could answer precisely are the ones that kept them.

Presented by PrimeBodyRx.com
The Associate Channel

Corporate pharmacy sales professionals and entrepreneurs are already building recurring revenue in this category through the Associate channel. Explore the Associate channel →

2024 · FALL
5 MIN
MARKET

The front door moved

Telehealth made cash-pay medicine normal, and the medspa boom followed — U.S. medspas nearly doubled since 2018, on a trajectory toward 12,000+ locations. Patients stopped waiting on insurance and started expecting concierge speed from every practice they walk into. The best practice: be ready to consult, prescribe, ship, and finance in the same visit, because the patient who has to "think about it" is the patient who never comes back.

Presented by PrimeBodyRx.com
2024 · SUMMER
6 MIN
WEALTH

The trillion-dollar signal

Eli Lilly became the first pharmaceutical company in history to cross $1 trillion in market value, powered by GLP-1 drugs. Wall Street’s answer was fast: J.P. Morgan projected the incretin market at $200 billion by 2030. The best practice the field took from 2024: when capital moves at that size, the services layer around it — prescribing, fulfillment, financing — is where practices capture durable value. The molecule makers got rich first. The practice economy is next.

Presented by PrimeBodyRx.com
03 · THE LEADING VOICES

The doctors who wrote the category’s vocabulary

From TED stages to the most-cited podcasts in medicine, these are the clinicians and scientists whose work built the category the market is now funding. Start anywhere — their lectures, books, and interviews are the curriculum.

Dr. Peter Attia

PHYSICIAN · AUTHOR, OUTLIVE

The category’s translator. His TED talks and The Drive podcast moved longevity from the lab to the living room — and "Medicine 3.0" into practice economics.

Dr. David Sinclair

HARVARD GENETICIST · AUTHOR, LIFESPAN

His TED talk on why we age remains one of the most-watched in the field. The sirtuin and information-theory work behind half the NAD+ industry.

Dr. Andrew Huberman

STANFORD NEUROSCIENTIST · HUBERMAN LAB

Brought the mind discipline to millions — sleep, light, dopamine, protocol-driven behavior. Proof the category is neurology as much as endocrinology.

Dr. Mark Hyman

FUNCTIONAL MEDICINE PIONEER

Made food-as-medicine a working clinic model and a bestseller shelf. The bridge from traditional practice to longevity practice design.

Dr. Valter Longo

USC · CREATOR, FASTING-MIMICKING DIET

Turned fasting science into a clinical protocol used in practices worldwide — the model for a measured, sellable, repeatable program.

Dr. Nir Barzilai

EINSTEIN COLLEGE OF MEDICINE · TAME TRIAL

Leading the scientific case that aging itself is a treatable condition — the trial the FDA world is watching.

Dr. Gabrielle Lyon

MUSCLE-CENTRIC MEDICINE · AUTHOR, FOREVER STRONG

Made lean mass the clinical priority of the category — and gave practices the protocol with the best adherence in the field.

Dr. Peter Diamandis

XPRIZE FOUNDER · FOUNTAIN LIFE

Made longevity investable at planetary scale — the $101M Healthspan prize and the longevity-clinic chain model.

Bryan Johnson

BLUEPRINT · THE CIVILIAN PROOF

Not a physician — the civilian who made protocols a headline, a movement, and then a $60M company. The demand curve, personified.

04 · THE WEALTH, BEING CREATED NOW

Positive stories, real money, honest math

THE MOLECULE MAKERS

The first trillion

Eli Lilly’s climb past $1 trillion in market value on GLP-1s, with Novo Nordisk beside it as Europe’s most valuable company — the fastest wealth creation in pharmaceutical history, built on the same molecules your practice prescribes.

THE PRACTICE OWNERS

$21B to $78B

The medspa and longevity-clinic economy is compounding at roughly 16% a year. The winners are ordinary practice owners who added recurring protocol revenue — GLP-1 management, peptide programs, hormones — to rooms they already owned.

THE CHANNEL BUILDERS

The associate economy

The newest layer: professionals who represent platforms to practices — corporate pharmacy sales pros, entrepreneurs, and fitness coaches earning recurring revenue for the life of every account they open. The same B2B wealth model that built every great distribution industry, arriving in longevity.

05 · THE PRIMEBODYMIND PLAYBOOK

Seven best practices, distilled from the record

  • 01 — Sell the system, not the syringe. Protocols as memberships, not injections as transactions. Recurring revenue is the entire model.
  • 02 — Meet the informed patient with documentation. They arrive holding a podcast. Answer it with clinical precision or lose them to someone who will.
  • 03 — Close in the same visit. A high-ticket plan without financing at the point of decision is a plan that dies in the follow-up call.
  • 04 — Buy wholesale, always. 503A/503B sourcing networks exist so practices stop paying retail and start compounding margin.
  • 05 — One login beats nine subscriptions. Fragmented software is the silent tax on every practice that hasn’t consolidated.
  • 06 — Choose the clinical channel, not the consumer channel. The gray market is being banned; the compliance-first practice economy is being built. One of them has a future.
  • 07 — Position before the wave, not on it. XPRIZE therapies, GLP-1 expansion, and clinic consolidation are all moving in one direction. Early with standards beats late with budget.
06 · NOTES FROM THE FOUNDER’S DESK

Why this journal exists

I’ve spent my career building sales organizations and healthcare commerce infrastructure — turning fast-growing categories into systems that work on a Tuesday morning, not just in a pitch deck. I don’t claim to be the smartest person in longevity. I’ve simply been in enough emerging markets to know what an organized one looks like when it arrives, and this is that.

PrimeBodyMind is my running record of it: the doctors worth reading, the numbers worth trusting, the practices worth copying, and the wealth being created — honestly, transparently, and mostly by unglamorous people who showed up early and did the work. If it helps you see the category more clearly, it has done its job.

One life. This is it. Build accordingly.

Brookes BrunoFounder, PrimeBodyRX · primebodyrx.com · September 2026
07 · THE JOURNAL — NEWS · DIET · TRAINING · ALIGNMENT

The full-scope journal

Serious reading for people who take the long view — metabolic science, disciplined eating, training that ages well, and the alignment everything else sits on. No fluff, no fads, no filler.

NEWS4 MIN

The Longevity Category Isn't Coming. It's Here.

GLP-1 management, peptide programs, and clinic economics compounding at double digits — what it means for practice owners positioned correctly.

Read the article →
NEWS5 MIN

What We're Reading This Month

Three threads worth a clinician's attention: metabolic maintenance dosing, recovery consistency, and overnight glucose stability.

Read the article →
DIET5 MIN

Keto, Done Like an Adult

Protein first, electrolytes serious, a measured 30-day run, and an exit strategy. Ketogenic eating as a discipline — not a personality.

Read the article →
DIET4 MIN

The Carnivore Question, Answered Plainly

What the evidence supports, what it doesn't, and who the approach actually serves. No cheering, no sneering.

Read the article →
DIET4 MIN

Low-Glycemic Living: The Quiet Workhorse

Glycemic control is the most underrated longevity lever — and the easiest to implement badly. Here's the adult version.

Read the article →
RECIPES5 MIN

The 15-Minute Low-Glycemic Kitchen

Three plates in fifteen minutes each — breakfast, lunch, dinner — with macros noted and no recipe worth forgetting.

Read the article →
RECIPES6 MIN

Keto Meal Prep for a 6-Day Week

One ninety-minute Sunday session, a 2-2-1 framework, four recipes. Six days of clean keto eating for people with actual jobs.

Read the article →
WORKING OUT5 MIN

Advanced Yoga, Longevity-Style

Crow pose, loaded holds, breath discipline, joint longevity. Yoga as strength training for a hundred-year body.

Read the article →
WORKING OUT5 MIN

Weight Training for the Long Game

Load management, the zone 2 balance, and why the barbell matters more at 60 than at 25.

Read the article →
WORKING OUT4 MIN

The Recovery Session: The Workout Nobody Skips Twice

Sleep, mobility, active rest — the session your numbers recover with. Skip it twice and you'll stop skipping it.

Read the article →
ALIGNMENT5 MIN

Alignment: The Word We Mean Literally

Posture, breath, spine, and nervous-system regulation — the literal foundation everything else sits on.

Read the article →
ALIGNMENT3 MIN

The 20-Minute Reset

Breath, mobility, light, stillness. Twenty minutes a day that pair with every protocol above.

Read the article →

THE DAILY DEMO

See what the journal is built on.

Every insight in these pages comes from the platform itself — the sourcing, the clinical suite, the financing engine. See it live, on screen, with the senior team.